Forbes

Is The Rally In Veru Overdone?

Is The Rally In Veru Overdone?

After a stellar 3x rise since the March 23 levels of last year, at the current price of around $10 per share we believe Veru Inc. stock, a biopharmaceuticals company focused on oncology medicines, has reached its near-term potential. Veru stock has rallied from $3 to $10, significantly…

Source: Forbes – Markets
Date: January 12, 2021, 22:55